Britannia Life Sciences Inc. BLAB
CNSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 94.26% | 124.83% | 1,583.28% | -14.48% | 729.63% |
| Total Receivables | 639.17% | 416.32% | -48.98% | -82.71% | -86.82% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 190.43% | 99.41% | 270.68% | -54.68% | -62.85% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -74.93% | -74.08% | -- | -- | -- |
| Total Current Assets | 70.47% | 94.92% | 659.77% | 2.31% | 227.62% |
|
|
|||||
| Total Current Assets | 70.47% | 94.92% | 659.77% | 2.31% | 227.62% |
| Net Property, Plant & Equipment | -51.12% | -42.81% | -83.79% | -83.53% | -81.11% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 143.19% | 111.68% | 4.44% | -56.04% | -54.70% |
|
|
|||||
| Total Accounts Payable | -31.14% | -37.97% | 62.33% | -52.12% | -50.51% |
| Total Accrued Expenses | -1.22% | -12.93% | -12.13% | 92.68% | 172.41% |
| Short-term Debt | -3.69% | 2.45% | 7.07% | 0.47% | -79.83% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -11.50% | -1.25% | -92.68% | -93.06% | -92.12% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -7.56% | -19.35% | -56.95% | -74.44% | -75.69% |
|
|
|||||
| Total Current Liabilities | -7.56% | -19.35% | -56.95% | -74.44% | -75.69% |
| Long-Term Debt | -- | -- | -- | -56.00% | -64.27% |
| Short-term Debt | -3.69% | 2.45% | 7.07% | 0.47% | -79.83% |
| Capital Leases | -75.25% | -68.47% | -77.85% | -73.15% | -65.85% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -37.18% | -39.53% | -68.96% | -69.14% | -72.40% |
|
|
|||||
| Common Stock & APIC | -3.07% | 2.97% | 4.94% | -3.01% | 0.35% |
| Retained Earnings | 117.42% | 110.36% | 87.78% | 27.67% | 22.36% |
| Treasury Stock & Other | -15.50% | -22.77% | -1,189.05% | -449.39% | -84.57% |
| Total Common Equity | 281.81% | 239.10% | 1,429.92% | 222.68% | 191.58% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 281.81% | 239.10% | 1,429.92% | 222.68% | 191.58% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 281.81% | 239.10% | 209.86% | -21.19% | -10.63% |
|
|
|||||